FDA warns of increased risk of hypomagnesemia, or low magnesium levels, associated with PPI use.
2011 – FDA warns of hypomagnesemia risk
Announcement Date: March 2, 2011
FDA warns of increased risk of hypomagnesemia, or low magnesium levels, associated with PPI use.